Search PubMedSearch

Biomedical subjects

John W Newman

Publications and source records attributed to John W Newman.

3 recordsLinked to original sources

Tai Chi exercise of short duration alters circulating oxylipins in postmenopausal women: a pilot study.

Tai Chi (TC) is a low-impact physical activity known to improve balance, strength, and cognitive health across the lifespan. We previously reported that 8 weeks of TC altered brain connectivity and circulating oxylipins (OxLs) and endocannabinoids/endocannabinoid-like compounds (eCBs) in postmenopausal (PM) women with knee osteoarthritis. This pilot study examined whether a short TC intervention similarly affects inflammatory OxL and eCB in PM women. Participants completed four TC sessions on non-consecutive days over 10 days. Each session included 10 min of warm-up, 45 min of 24-form Yang-style TC (six repetitions at ~7 min per routine), and 5 min of cool-down. Non-fasting plasma collected at baseline and immediately after the fourth session was analyzed for OxL and eCB using targeted metabolomics. Partial least squares discriminant analysis (PLS-DA) assessed pre-to post-intervention differences, and paired t-tests with false discovery rate correction evaluated metabolite changes. Sixteen PM women (58.9 ± 5.2 years; BMI 33.6 ± 5.4 kg/m2) completed the study. Several OxLs demonstrated PLS-DA variable importance in projection scores >1.0. Post-intervention, 1-AG and 12-hydroxyeicosatetraenoic acid (12-HETE) were generally lower, whereas 18-HEPE was higher. TC produced modest effects on eCBs but more pronounced changes in OxLs. Reduced monoacylglycerols may indicate TC-induced mobilization of fatty acids through enzymes involved in 1-AG metabolism, including phospholipase C, diacylglycerol lipase-α, monoglyceride lipase, and potentially fatty acid amide hydrolase.

Tai Chi

Human brown fat metabolism associates with systemic branched-chain amino acids homeostasis.

Circulating branched-chain amino acids (BCAAs) are linked with insulin resistance, but the human tissues contributing to systemic BCAA homeostasis remain incompletely defined. Brown adipose tissue (BAT) is a metabolically active adipose depot associated with favourable insulin sensitivity, yet its role in BCAA metabolism in humans remains unclear. We tested whether human BAT metabolism is associated with circulating BCAA levels, BAT-resident BCAA-catabolic signatures, and longitudinal changes in systemic BCAA homeostasis. We studied 83 adults who underwent metabolic phenotyping, PET-CT assessment of cold-stimulated BAT metabolism, and serum metabolomic profiling at room temperature and during acute mild cold exposure. Supraclavicular BAT biopsies from 25 participants were analysed by transcriptomics and metabolomics, and 40 participants were re-examined for circulating BCAA profiles after approximately five years. Participants with high BAT metabolism had lower circulating BCAA levels than those with low BAT metabolism. Within BAT, metabolically active individuals exhibited lower relative BCAA abundance together with higher expression of genes involved in BCAA catabolism. These BAT BCAA-catabolic signatures aligned with thermogenic capacity and indices of systemic insulin sensitivity. In contrast, individuals with low BAT metabolism showed increases in circulating BCAAs over five years. Integrative analyses further linked circulating lipopolysaccharide, a marker of metabolic endotoxemia, with higher BAT BCAA and aminomalonate abundance, together with transcriptional patterns involving inflammatory and mitochondrial pathways. Together, these findings identify human BAT metabolism as a tissue phenotype linked to systemic BCAA homeostasis and extend the role of human BAT beyond thermogenesis, suggesting that BAT-associated BCAA handling may contribute to systemic metabolic health.

Humans

Supplementations of docosahexaenoic acid and blueberry suppress a high-fat breakfast-induced postprandial inflammation but only docosahexaenoic acid improves endothelial function in healthy adults: a randomized, double-blind, placebo-controlled crossover intervention study.

Blueberries and n - 3 polyunsaturated fatty acids each can provide protection against inflammation and cardiometabolic disorders. However, the underlying mechanisms are not fully understood. We hypothesized that blueberry and docosahexaenoic acid (DHA) can suppress high fat (HF) meal-induced postprandial inflammation and improve endothelial function. Sixty-two healthy participants (age: 26.8 &#xb1; 1.2 y; BMI: 22.1 &#xb1; 1.2 kg/m&#xb2;) consumed an isoenergetic breakfast (850 kcal) containing 34.7 g mostly animal fat (36% kcal), 25.3 g protein, and 111 g carbohydrate, with or without either 42.2 g blueberry powder (BBP) or 1.76 g DHA in a randomized, double-blind, placebo-controlled crossover intervention study. Blood samples were collected before and 1 h, 3 h and 6 h after breakfast. Monocyte activation, proinflammatory gene expression, cytokine production and endothelial function were assessed. Compared with the placebo control, DHA supplementation suppressed the HF breakfast-induced: expression of IL-1&#x3b2; by 21.6% (P < .01) and prostaglandin-endoperoxide synthase 2 (PTGS2, i.e., cyclooxygenase 2) by 22.8% (P < .01) at 6 h; plasma IL-1&#x3b2; production by 40.1 to 49.8% (P < .01) at 1-6 h; lipoprotein lipase (LPL)-treated blood IL-1&#x3b2; production by 40.9% (P < .0001) at 6 h; and total cholesterol/HDL cholesterol ratio by 2.2% (P < .01) at 3 h and 3.5% (P < .0001) at 6 h. BBP supplementation suppressed LPL-treated blood IL-1&#x3b2; production by 23.1% (P < .05) at 6 h. BBP and DHA also induced postprandial increases in reactive hyperemia index (RHI) scores relative to the fasting baselines, with DHA producing a 13.3% increase compared with placebo at 6 h (P < .05). In conclusion, supplementation with BBP or DHA suppressed the HF meal-induced postprandial inflammation but only DHA improved postprandial endothelial function. This study was registered at clinicaltrails.gov (NCT02472171).

Blueberry